251 related articles for article (PubMed ID: 8930008)
21. A double-blind placebo-controlled study of Org 3770 in depressed outpatients.
Claghorn JL; Lesem MD
J Affect Disord; 1995 Jun; 34(3):165-71. PubMed ID: 7560544
[TBL] [Abstract][Full Text] [Related]
22. A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients.
Høyberg OJ; Maragakis B; Mullin J; Norum D; Stordall E; Ekdahl P; Ose E; Moksnes KM; Sennef C
Acta Psychiatr Scand; 1996 Mar; 93(3):184-90. PubMed ID: 8739664
[TBL] [Abstract][Full Text] [Related]
23. The use of mirtazapine in a group of 11 patients following poor compliance to selective serotonin reuptake inhibitor treatment due to sexual dysfunction.
Koutouvidis N; Pratikakis M; Fotiadou A
Int Clin Psychopharmacol; 1999 Jul; 14(4):253-5. PubMed ID: 10468319
[TBL] [Abstract][Full Text] [Related]
24. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.
Wade A; Crawford GM; Angus M; Wilson R; Hamilton L
Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891
[TBL] [Abstract][Full Text] [Related]
25. A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression.
Marttila M; Jääskeläinen J; Järvi R; Romanov M; Miettinen E; Sorri P; Ahlfors U; Zivkov M
Eur Neuropsychopharmacol; 1995 Dec; 5(4):441-6. PubMed ID: 8998395
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
Fava M; Dunner DL; Greist JH; Preskorn SH; Trivedi MH; Zajecka J; Cohen M
J Clin Psychiatry; 2001 Jun; 62(6):413-20. PubMed ID: 11465517
[TBL] [Abstract][Full Text] [Related]
27. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects.
Stimmel GL; Dopheide JA; Stahl SM
Pharmacotherapy; 1997; 17(1):10-21. PubMed ID: 9017762
[TBL] [Abstract][Full Text] [Related]
28. Mirtazapine: a newer antidepressant.
Hartmann PM
Am Fam Physician; 1999 Jan; 59(1):159-61. PubMed ID: 9917581
[TBL] [Abstract][Full Text] [Related]
29. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
Guelfi JD; Ansseau M; Timmerman L; Kørsgaard S;
J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127
[TBL] [Abstract][Full Text] [Related]
30. COMBINED MIRTAZAPINE AND SSRI TREATMENT OF PTSD: A PLACEBO-CONTROLLED TRIAL.
Schneier FR; Campeas R; Carcamo J; Glass A; Lewis-Fernandez R; Neria Y; Sanchez-Lacay A; Vermes D; Wall MM
Depress Anxiety; 2015 Aug; 32(8):570-9. PubMed ID: 26115513
[TBL] [Abstract][Full Text] [Related]
31. Mirtazapine, an antidepressant.
Puzantian T
Am J Health Syst Pharm; 1998 Jan; 55(1):44-9. PubMed ID: 9437474
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitriptyline.
Kasper S; Zivkov M; Roes KC; Pols AG
Eur Neuropsychopharmacol; 1997 May; 7(2):115-24. PubMed ID: 9169299
[TBL] [Abstract][Full Text] [Related]
33. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
Carpenter LL; Yasmin S; Price LH
Biol Psychiatry; 2002 Jan; 51(2):183-8. PubMed ID: 11822997
[TBL] [Abstract][Full Text] [Related]
34. Hypertension during coprescription of mirtazapine and low-dose amitriptyline.
Zedkova L; Coupland NJ
Can J Psychiatry; 1998 Oct; 43(8):858-9. PubMed ID: 9806099
[No Abstract] [Full Text] [Related]
35. [Selective serotonin reuptake inhibitor is more likely to induce sexual dysfunction than mirtazapine in treating depression].
Chen ZX; Wang HQ; Jin WD
Zhonghua Nan Ke Xue; 2008 Oct; 14(10):896-9. PubMed ID: 19157098
[TBL] [Abstract][Full Text] [Related]
36. Efficacy, tolerability, and preference of mirtazapine orally disintegrating tablets in depressed patients: a 17-week naturalistic study in Lithuania.
Danileviciūte V; Sveikata A; Adomaitiene V; Gumbrevicius G; Fokas V; Sveikatiene R
Medicina (Kaunas); 2009; 45(10):778-84. PubMed ID: 19996664
[TBL] [Abstract][Full Text] [Related]
37. Mirtazapine-associated hyponatremia presenting as delirium.
Ghosh A; Hegde A; Grover S
Indian J Pharmacol; 2014; 46(4):448-9. PubMed ID: 25097290
[TBL] [Abstract][Full Text] [Related]
38. Mirtazapine augmentation in the treatment of refractory depression.
Carpenter LL; Jocic Z; Hall JM; Rasmussen SA; Price LH
J Clin Psychiatry; 1999 Jan; 60(1):45-9. PubMed ID: 10074878
[TBL] [Abstract][Full Text] [Related]
39. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of mirtazapine in clinically relevant subgroups of depressed patients.
Nutt DJ
Depress Anxiety; 1998; 7 Suppl 1():7-10. PubMed ID: 9597345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
